Related Experiment Videos
The use of tiagabine in affective disorders
M G Carta1, M C Hardoy, H Grunze
1Psychiatric Unit, Department of Public Health, University of Cagliari, Via Liguria 13, 09127 Cagliari, Italy. mgcarta@tiscalinet.it
Pharmacopsychiatry
|January 31, 2002
Abstract:
We reviewed the available literature on the efficacy of a novel anticonvulsant, Tiagabine (TGB), in the treatment of bipolar disorder. Study results indicate that TGB does not represent a valid option in acute mania due its required slow, progressive titration. More rapid titration schemes may lead to severe complications. TGB may be an option as an adjunct long-term treatment approach in refractory patients, but further studies are clearly needed to support this.